A detailed history of First Interstate Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First Interstate Bank holds 201 shares of REGN stock, worth $141,071. This represents 0.01% of its overall portfolio holdings.

Number of Shares
201
Previous 200 0.5%
Holding current value
$141,071
Previous $210,000 0.48%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$1024.09 - $1201.76 $1,024 - $1,201
1 Added 0.5%
201 $211,000
Q2 2024

Aug 07, 2024

BUY
$883.2 - $1071.19 $176,640 - $214,238
200 New
200 $210,000
Q3 2022

Oct 25, 2022

BUY
$573.97 - $724.32 $10,331 - $13,037
18 Added 4.8%
393 $270,000
Q2 2021

Jul 29, 2021

BUY
$472.8 - $558.54 $177,300 - $209,452
375 New
375 $209,000
Q4 2020

Feb 03, 2021

SELL
$478.3 - $607.98 $188,928 - $240,152
-395 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$544.75 - $658.21 $1.13 Million - $1.36 Million
-2,070 Reduced 83.98%
395 $221,000
Q2 2020

Aug 05, 2020

BUY
$493.32 - $643.92 $429,188 - $560,210
870 Added 54.55%
2,465 $1.54 Million
Q1 2020

May 11, 2020

SELL
$336.18 - $494.43 $79,674 - $117,179
-237 Reduced 12.94%
1,595 $779,000
Q4 2019

Feb 06, 2020

SELL
$274.13 - $376.51 $43,038 - $59,112
-157 Reduced 7.89%
1,832 $688,000
Q3 2019

Oct 30, 2019

BUY
$273.46 - $318.39 $4,375 - $5,094
16 Added 0.81%
1,989 $552,000
Q2 2019

Aug 05, 2019

SELL
$299.6 - $414.82 $27,263 - $37,748
-91 Reduced 4.41%
1,973 $618,000
Q3 2018

Nov 07, 2018

SELL
$351.14 - $408.51 $37,220 - $43,302
-106 Reduced 4.88%
2,064 $834,000
Q2 2018

Jul 27, 2018

SELL
$284.6 - $344.99 $3,699 - $4,484
-13 Reduced 0.6%
2,170 $749,000
Q1 2018

Apr 26, 2018

BUY
$315.82 - $393.78 $221,389 - $276,039
701 Added 47.3%
2,183 $752,000
Q4 2017

Feb 13, 2018

BUY
$358.63 - $469.95 $45,187 - $59,213
126 Added 9.29%
1,482 $557,000
Q3 2017

Nov 08, 2017

BUY
$431.38 - $504.0 $584,951 - $683,424
1,356
1,356 $606,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track First Interstate Bank Portfolio

Follow First Interstate Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Interstate Bank with notifications on news.